What Every Injector Needs to Know About Product Storage in Canada

Written By Ahmed Rashed

In medical aesthetics, safe storage is just as important as safe injection technique. Across Ontario and Canada, licensed injectors must follow strict storage protocols for botulinum toxin, dermal fillers, and other injectable products to ensure safety, product efficacy, and regulatory compliance.

Improper storage can compromise treatment outcomes, increase the risk of complications, and potentially violate Health Canada guidelines. Here’s what every injector should understand about proper product storage.

1. Temperature Control

Maintaining the correct temperature is critical for preserving product stability and effectiveness.

Botulinum Toxin (Botox®, Dysport®, Xeomin®, Nuceiva®)

• Store refrigerated at 2–8°C (36–46°F) before reconstitution.
• After reconstitution, use within the manufacturer’s recommended timeframe.
• Never freeze the product.

Dermal Fillers

• Most hyaluronic acid-based fillers should be stored at room temperature (2–25°C / 36–77°F).
• Avoid excessive heat exposure.
• Do not freeze unless explicitly stated by the manufacturer.

Using a dedicated, medical-grade refrigerator with temperature monitoring is strongly recommended in Ontario clinics.

2. Light Protection

Some injectable products are sensitive to light exposure.

Best practices include:

• Keeping products in original packaging until use
• Storing vials away from direct sunlight
• Avoiding exposure to strong UV lighting

Proper light protection helps preserve potency and product integrity.

3. Preventing Contamination

Strict aseptic technique is essential when handling injectable products.

Key safety measures include:

• Using sterile gloves and equipment
• Never sharing single-use vials between patients
• Following manufacturer guidelines for multi-dose vials
• Discarding unused reconstituted product according to protocol

Infection prevention and control (IPAC) standards must be followed in Ontario and across Canada.

4. Stock Rotation and Expiry Management

Injectors should follow the “First In, First Out (FIFO)” method.

This includes:

• Regularly checking expiration dates
• Using older inventory before newer stock
• Disposing of expired products safely
• Maintaining accurate inventory logs

Expired or improperly stored products should never be used, as this can compromise patient safety and clinic compliance.

5. Secure Storage and Documentation

Injectable products must be stored securely to prevent unauthorized access.

Best practices include:

• Locked medical refrigerators or cabinets
• Access limited to authorized healthcare professionals
• Detailed inventory documentation
• Recording batch numbers and expiry dates

Proper documentation ensures traceability in the event of a product recall or adverse reaction investigation.

6. Safe Transport Between Locations

For injectors offering mobile services or working across multiple clinics in Ontario, safe transport is critical.

Use:

• Insulated, medical-grade coolers
• Temperature-monitoring devices
• Ice packs designed for pharmaceutical transport

Maintaining cold chain integrity protects product effectiveness during transit.

Final Word: Storage Is a Patient Safety Standard

Correct product storage is not optional—it is a core component of safe injectable practice in Canada. Improperly stored botulinum toxin or dermal fillers can lead to reduced efficacy, unexpected outcomes, or regulatory consequences.

At Chellsey Institute of Beauty & Health, Injectables Training Programs emphasize not only injection techniques but also product handling, storage compliance, and clinical best practices.

By combining advanced clinical skills with responsible storage management, you protect your clients, your professional reputation, and your long-term success in medical aesthetics.